| Item Type | Name |
|
Academic Article
|
Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.
|
|
Academic Article
|
Treatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom setting.
|
|
Academic Article
|
A randomized, double-blind study of 30 versus 20 mg dexmethylphenidate extended-release in children with attention-deficit/hyperactivity disorder: late-day symptom control.
|
|
Academic Article
|
A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.
|
|
Academic Article
|
Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.
|
|
Academic Article
|
Duration of effect of oral long-acting stimulant medications for ADHD throughout the day.
|
|
Academic Article
|
ADHD in adults: current treatment trends with consideration of abuse potential of medications.
|
|
Concept
|
Central Nervous System Stimulants
|
|
Academic Article
|
A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.
|
|
Academic Article
|
Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
|
|
Academic Article
|
SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study.
|
|
Academic Article
|
Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting.
|
|
Academic Article
|
Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder.
|
|
Academic Article
|
Changes in emotions related to medication used to treat ADHD. Part II: clinical approaches.
|
|
Academic Article
|
Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults.
|
|
Academic Article
|
Changes in emotions related to medication used to treat ADHD. Part I: literature review.
|
|
Academic Article
|
Academic, behavioral, and cognitive effects of OROS? methylphenidate on older children with attention-deficit/hyperactivity disorder.
|
|
Academic Article
|
Effect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
|
|
Academic Article
|
Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.
|
|
Academic Article
|
Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.
|
|
Academic Article
|
Effects of open-label lisdexamfetamine dimesylate on self-reported quality of life in adults with ADHD.
|
|
Academic Article
|
Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.
|
|
Academic Article
|
Extended-release dexmethylphenidate 30 mg/d versus 20 mg/d: duration of attention, behavior, and performance benefits in children with attention-deficit/hyperactivity disorder.
|
|
Academic Article
|
Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate.
|
|
Academic Article
|
The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.
|
|
Academic Article
|
Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
|
|
Academic Article
|
A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design.
|
|
Academic Article
|
A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.
|
|
Academic Article
|
Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study.
|
|
Academic Article
|
A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder.
|
|
Academic Article
|
Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study.
|